Tag: for-patients

Breast Cancer Drug Launched To Help Women Who Have Stopped Responding To Herceptin

A breast cancer drug for women who have stopped responding to Herceptin has been launched in the UK. Kadcyla – also called T-DM1 – is given to patients who have failed on conventional treatment with Herceptin and chemotherapy

Continue Reading

Astellas Pharma, MD Anderson sign option agreement to research and develop new treatment for AML

| April 6, 2015 | 0 Comments

Astellas Pharma Inc. and The University of Texas MD Anderson Cancer Center today announced the signing of an option agreement to research and develop a new treatment for patients with acute myeloid leukemia (AML).

Continue Reading

MD Anderson, Astellas Pharma sign option agreement for monoclonal antibody drug targeting acute myeloid leukemia

| April 3, 2015 | 0 Comments

( University of Texas M. D. Anderson Cancer Center ) The University of Texas MD Anderson Cancer Center and Astellas Pharma Inc.

Continue Reading

MD Anderson, Astellas Pharma Sign Option Agreement

| April 3, 2015 | 0 Comments

The University of Texas MD Anderson Cancer Center and Astellas Pharma Inc.

Continue Reading

Latest cancer treatment proves safest, most comfortable

| March 12, 2015 | 0 Comments

State of the art radiotherapy treatment at Wellington Hospital is providing faster, more effective cancer treatment with fewer side-effects for patients, a radiation oncologist says.

Continue Reading

Latest cancer treatment proves safest and most comfortable

| March 12, 2015 | 0 Comments

State of the art radiotherapy treatment at Wellington Hospital is providing faster, more effective cancer treatment with fewer side-effects for patients, a radiation oncologist says.

Continue Reading

New model proposed for predicting outcomes more accurately in HPV-related throat cancer patients

| March 9, 2015 | 0 Comments

Researchers at the Princess Margaret Cancer Centre are proposing a new model to enable doctors to predict outcomes more accurately for patients with throat cancers specifically caused by Human Papillomavirus (HPV).

Continue Reading

New device treats brain tumors without chemotherapy, radiation

| March 8, 2015 | 0 Comments

Survival for patients suffering from glioblastoma, a deadly form of brain cancer, is often measured in months. But a new device is offering hope and improving quality of life by shrinking tumors without the need for chemotherapy and radiation treatments

Continue Reading

FDA approves Bristol-Myers Squibb's Opdivo to treat lung cancer

| March 4, 2015 | 0 Comments

NEW YORK (MarketWatch) — The U.S. Food and Drug Administration said Wednesday it has approved Bristol-Myers Squibb Co.’s Opdivo as a treatment for lung cancer, the leading cause of cancer death in the country.

Continue Reading

Novartis lung cancer drug Zykadia® recommended for EU approval in patients with ALK+ NSCLC previously treated with …

| February 27, 2015 | 0 Comments

If approved, Zykadia (ceritinib) would be the first treatment option for patients in Europe with ALK+ NSCLC previously treated with crizotinib   ALK+ NSCLC is driven by a rearrangement of the ALK gene, …

Continue Reading